Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Kostas Kosmatopoulos
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Living Beings
Anatomy
Chemicals & Drugs
Physiology
Procedures
Genes & Molecular Sequences
Concepts & Ideas
Sign-in to see full Profile
Network (preview)
14
Lemonnier, François
12
Gross, David-Alexandre
12
Scardino, Antonio
10
Chouaib, Salem
9
Orbach-Arbouys, Simone
9
Oukka, Mohamed
8
Miconnet, Isabelle
8
Faure, Olivier
8
Graff-Dubois, Stéphanie
8
Cornet, Sébastien
7
Firat, Hueseyin
7
Tourdot, Sophie
6
Alves, Pedro
5
Cordopatis, Paul
5
Lemonnier, François
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Kostas Kosmatopoulos (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Menez-Jamet Jeanne; Kosmatopoulos Kostas
Development of optimized cryptic peptides for immunotherapy.
IDrugs : the investigational drugs journal 2009;12(2):98-102.
-
2007: Mars Lennart T; Bauer Jan; Gross David A; Bucciarelli Florence; Firat Huseyin; Hudrisier Denis; Lemonnier François; Kosmatopoulos Kostas; Liblau Roland S
CD8 T cell responses to myelin oligodendrocyte glycoprotein-derived peptides in humanized HLA-A*0201-transgenic mice.
Journal of immunology (Baltimore, Md. : 1950) 2007;179(8):5090-8.
-
2007: Scardino Antonio; Alimandi Maurizio; Correale Pierpaolo; Smith Steven G; Bei Roberto; Firat Hüseyin; Cusi Maria Grazia; Faure Olivier; Graf-Dubois Stephanie; Cencioni Giulia; Marrocco Jordan; Chouaib Salem; Lemonnier François A; Jackson Andrew Michael; Kosmatopoulos Kostas
A polyepitope DNA vaccine targeted to Her-2/ErbB-2 elicits a broad range of human and murine CTL effectors to protect against tumor challenge.
Cancer research 2007;67(14):7028-36.
-
2007: Bolonaki Irini; Kotsakis Athanassios; Papadimitraki Elsa; Aggouraki Despoina; Konsolakis George; Vagia Aphrodite; Christophylakis Charalambos; Nikoloudi Irini; Magganas Elefterios; Galanis Athanassios; Cordopatis Paul; Kosmatopoulos Kostas; Georgoulias Vassilis; Mavroudis Dimitris
Vaccination of patients with advanced non-small-cell lung cancer with an optimized cryptic human telomerase reverse transcriptase peptide.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(19):2727-34.
-
2007: Faure Olivier; Graff-Dubois Stéphanie; Alves Pedro M S; Cornet Sébastien; Duffour Marie-Thérèse; Scardino Antonio; Gross David-Alexandre; Miconnet Isabelle; Salcedo Margarita; Chouaib Salem; Lemonnier François A; Abastado Jean-Pierre; Kosmatopoulos Kostas
Induction of multiple CD8+ T cell responses against the inducible Hsp70 employing an Hsp70 oligoepitope peptide.
Oncology reports 2007;17(3):679-85.
-
2006: Alves Pedro M S; Faure Olivier; Graff-Dubois Stéphanie; Cornet Sebastien; Bolonakis Irena; Gross David-Alexandre; Miconnet Isabelle; Chouaib Salem; Fizazi Karim; Soria Jean Charles; Lemonnier François A; Kosmatopoulos Kostas
STEAP, a prostate tumor antigen, is a target of human CD8+ T cells.
Cancer immunology, immunotherapy : CII 2006;55(12):1515-23.
-
2006: Cornet Sébastien; Miconnet Isabelle; Menez Jeanne; Lemonnier François; Kosmatopoulos Kostas
Optimal organization of a polypeptide-based candidate cancer vaccine composed of cryptic tumor peptides with enhanced immunogenicity.
Vaccine 2006;24(12):2102-9.
-
2006: Cornet Sébastien; Menez-Jamet Jeanne; Lemonnier François; Kosmatopoulos Kostas; Miconnet Isabelle
CpG oligodeoxynucleotides activate dendritic cells in vivo and induce a functional and protective vaccine immunity against a TERT derived modified cryptic MHC class I-restricted epitope.
Vaccine 2006;24(11):1880-8.
-
2006: Mavroudis D; Bolonakis I; Cornet S; Myllaki G; Kanellou P; Kotsakis A; Galanis A; Nikoloudi I; Spyropoulou M; Menez J; Miconnet I; Niniraki M; Cordopatis P; Kosmatopoulos K; Georgoulias V
A phase I study of the optimized cryptic peptide TERT(572y) in patients with advanced malignancies.
Oncology 2006;70(4):306-14.
-
2004: Haining W Nicholas; Anderson Daniel G; Little Steven R; von Bergwelt-Baildon Michael S; Cardoso Angelo A; Alves Pedro; Kosmatopoulos Kostas; Nadler Lee M; Langer Robert; Kohane Daniel S;
pH-triggered microparticles for peptide vaccination.
Journal of immunology (Baltimore, Md. : 1950) 2004;173(4):2578-85.
-
2004: Faure Olivier; Graff-Dubois Stéphanie; Bretaudeau Laurent; Derré Laurent; Gross David-Alexandre; Alves Pedro M S; Cornet Sébastien; Duffour Marie-Thérèse; Chouaib Salem; Miconnet Isabelle; Grégoire Marc; Jotereau Francine; Lemonnier François A; Abastado Jean-Pierre; Kosmatopoulos Kostas
Inducible Hsp70 as target of anticancer immunotherapy: Identification of HLA-A*0201-restricted epitopes.
International journal of cancer. Journal international du cancer 2004;108(6):863-70.
-
2004: Gross David-Alexandre; Graff-Dubois Stéphanie; Opolon Paule; Cornet Sébastien; Alves Pedro; Bennaceur-Griscelli Annelise; Faure Olivier; Guillaume Philippe; Firat Hüseyin; Chouaib Salem; Lemonnier François A; Davoust Jean; Miconnet Isabelle; Vonderheide Robert H; Kosmatopoulos Kostas
High vaccination efficiency of low-affinity epitopes in antitumor immunotherapy.
The Journal of clinical investigation 2004;113(3):425-33.
-
2003: Alves Pedro M S; Faure Olivier; Graff-Dubois Stéphanie; Gross David-Alexandre; Cornet Sébastien; Chouaib Salem; Miconnet Isabelle; Lemonnier François A; Kosmatopoulos Kostas
EphA2 as target of anticancer immunotherapy: identification of HLA-A*0201-restricted epitopes.
Cancer research 2003;63(23):8476-80.
-
2003: Plonquet Anne; Garcia-Pons Francisco; Fernandez Eric; Philippe Caramelle; Marquet Jeanine; Rouard Hélène; Delfau-Larue Marie Hélène; Kosmatopoulos Konstantinos; Lemonnier François; Farcet Jean Pierre; Gherardi Romain K; Langlade-Demoyen Pierre
Peptides derived from the onconeural HuD protein can elicit cytotoxic responses in HHD mouse and human.
Journal of neuroimmunology 2003;142(1-2):93-100.
-
2003: Scardino A; Correale P; Firat H; Pellegrini M; Kosmatopoulos K; Opolon P; Alves P; Zurbriggen R; Glück R; Lemonnier F A; Francini G; Cusi M G
In vivo study of the GC90/IRIV vaccine for immune response and autoimmunity into a novel humanised transgenic mouse.
British journal of cancer 2003;89(1):199-205.
-
2003: Nizard Philippe; Gross David Alexandre; Babon Aurélie; Chenal Alexandre; Beaumelle Bruno; Kosmatopoulos Konstadinos; Gillet Daniel
Anchoring cytokines to tumor cells for the preparation of anticancer vaccines without gene transfection in mice.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2003;26(1):63-71.
-
2002: Francini Guido; Scardino Antonio; Kosmatopoulos Kostas; Lemonnier François A; Campoccia Giuseppe; Sabatino Marianna; Pozzessere Daniele; Petrioli Roberto; Lozzi Luisa; Neri Paolo; Fanetti Giuseppe; Cusi Maria Grazia; Correale Pierpaolo
High-affinity HLA-A(*)02.01 peptides from parathyroid hormone-related protein generate in vitro and in vivo antitumor CTL response without autoimmune side effects.
Journal of immunology (Baltimore, Md. : 1950) 2002;169(9):4840-9.
-
2002: Graff-Dubois Stéphanie; Faure Olivier; Gross David-Alexandre; Alves Pedro; Scardino Antonio; Chouaib Salem; Lemonnier François A; Kosmatopoulos Kostas
Generation of CTL recognizing an HLA-A*0201-restricted epitope shared by MAGE-A1, -A2, -A3, -A4, -A6, -A10, and -A12 tumor antigens: implication in a broad-spectrum tumor immunotherapy.
Journal of immunology (Baltimore, Md. : 1950) 2002;169(1):575-80.
-
2002: Scardino Antonio; Gross David-Alexandre; Alves Pedro; Schultze Joachim L; Graff-Dubois Stéphanie; Faure Olivier; Tourdot Sophie; Chouaib Salem; Nadler Lee M; Lemonnier François A; Vonderheide Robert H; Cardoso Angelo A; Kosmatopoulos Kostas
HER-2/neu and hTERT cryptic epitopes as novel targets for broad spectrum tumor immunotherapy.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(11):5900-6.
-
2002: Passoni Lorena; Scardino Antonio; Bertazzoli Carla; Gallo Barbara; Coluccia Addolorata M L; Lemonnier François A; Kosmatopoulos Konstadinos; Gambacorti-Passerini Carlo
ALK as a novel lymphoma-associated tumor antigen: identification of 2 HLA-A2.1-restricted CD8+ T-cell epitopes.
Blood 2002;99(6):2100-6.
-
2002: Dangles Virginie; Halberstam Ilan; Scardino Antonio; Choppin Jeannine; Wertheimer Mireille; Richon Sophie; Quelvennec Erwann; Moirand Romain; Guillet Jean-Gérard; Kosmatopoulos Kostas; Bellet Dominique; Zeliszewski Dominique
Tumor-associated antigen human chorionic gonadotropin beta contains numerous antigenic determinants recognized by in vitro-induced CD8+ and CD4+ T lymphocytes.
Cancer immunology, immunotherapy : CII 2002;50(12):673-81.
-
2001: Scardino A; Alves P; Gross D A; Tourdot S; Graff-Dubois S; Angevin E; Firat H; Chouaib S; Lemonnier F; Nadler L M; Cardoso A A; Kosmatopoulos K
Identification of HER-2/neu immunogenic epitopes presented by renal cell carcinoma and other human epithelial tumors.
European journal of immunology 2001;31(11):3261-70.
-
2001: Firat H; Tourdot S; Ureta-Vidal A; Scardino A; Suhrbier A; Buseyne F; Rivìere Y; Danos O; Michel M L; Kosmatopoulos K; Lemonnier F A
Design of a polyepitope construct for the induction of HLA-A0201-restricted HIV 1-specific CTL responses using HLA-A*0201 transgenic, H-2 class I KO mice.
European journal of immunology 2001;31(10):3064-74.
-
2001: Chouaib S; Echchakir H; Angevin E; Guerra N; Kosmatopoulos K; Caignard A; Lim A; Baron V; Ferradini L; Mami-Chouaib F
[Technological advances in immuno-oncology: from fundamental concepts to patient immunological monitoring]
Bulletin du cancer 2001;88(8):733-40.
-
2001: Nizard P; Gross D A; Chenal A; Beaumelle B; Kosmatopoulos K; Gillet D
[Anchoring cytokines to cancer cells using diphtheria toxin: better than immunotherapy by gene transfer?]
Journal de la Société de biologie 2001;195(3):229-34.
-
2000: Tourdot S; Scardino A; Saloustrou E; Gross D A; Pascolo S; Cordopatis P; Lemonnier F A; Kosmatopoulos K
A general strategy to enhance immunogenicity of low-affinity HLA-A2. 1-associated peptides: implication in the identification of cryptic tumor epitopes.
European journal of immunology 2000;30(12):3411-21.
-
2000: Cornet A; Bettelli E; Oukka M; Cambouris C; Avellana-Adalid V; Kosmatopoulos K; Liblau R S
Role of astrocytes in antigen presentation and naive T-cell activation.
Journal of neuroimmunology 2000;106(1-2):69-77.
-
1999: Firat H; Garcia-Pons F; Tourdot S; Pascolo S; Scardino A; Garcia Z; Michel M L; Jack R W; Jung G; Kosmatopoulos K; Mateo L; Suhrbier A; Lemonnier F A; Langlade-Demoyen P
H-2 class I knockout, HLA-A2.1-transgenic mice: a versatile animal model for preclinical evaluation of antitumor immunotherapeutic strategies.
European journal of immunology 1999;29(10):3112-21.
-
1997: Oukka M; Galou M; Belkaid Y; Tricotet V; Riche N; Reynes M; Kosmatopoulos K
Major histocompatibility complex class I presentation of exogenously acquired minor alloantigens initiates skin allograft rejection.
European journal of immunology 1997;27(12):3499-506.
-
1997: Tourdot S; Oukka M; Manuguerra J C; Magafa V; Vergnon I; Riché N; Bruley-Rosset M; Cordopatis P; Kosmatopoulos K
Chimeric peptides: a new approach to enhancing the immunogenicity of peptides with low MHC class I affinity: application in antiviral vaccination.
Journal of immunology (Baltimore, Md. : 1950) 1997;159(5):2391-8.
-
1997: Oukka M; Andre P; Turmel P; Besnard N; Angevin V; Karlsson L; Trans P L; Charron D; Bihain B; Kosmatopoulos K; Lotteau V
Selectivity of the major histocompatibility complex class II presentation pathway of cortical thymic epithelial cell lines.
European journal of immunology 1997;27(4):855-9.
-
1996: Oukka M; Manuguerra J C; Livaditis N; Tourdot S; Riche N; Vergnon I; Cordopatis P; Kosmatopoulos K
Protection against lethal viral infection by vaccination with nonimmunodominant peptides.
Journal of immunology (Baltimore, Md. : 1950) 1996;157(7):3039-45.
-
1996: Oukka M; Colucci-Guyon E; Tran P L; Cohen-Tannoudji M; Babinet C; Lotteau V; Kosmatopoulos K
CD4 T cell tolerance to nuclear proteins induced by medullary thymic epithelium.
Immunity 1996;4(6):545-53.
-
1996: Oukka M; Cohen-Tannoudji M; Tanaka Y; Babinet C; Kosmatopoulos K
Medullary thymic epithelial cells induce tolerance to intracellular proteins.
Journal of immunology (Baltimore, Md. : 1950) 1996;156(3):968-75.
-
1995: Churaqui E; Oukka M; Tilloy F; Mayadoux E; Bruley-Rosset M; Kosmatopoulos K
The J alpha segment contributes to the affinity of V beta 6+ cells for vSAG-7 (Mls-1a) presented by I-A molecules.
Immunology 1995;84(4):609-18.
-
1994: Cabaniols J P; Cibotti R; Kourilsky P; Kosmatopoulos K; Kanellopoulos J M
Dose-dependent T cell tolerance to an immunodominant self peptide.
European journal of immunology 1994;24(8):1743-9.
-
1994: Oukka M; Riché N; Kosmatopoulos K
A nonimmunodominant nucleoprotein-derived peptide is presented by influenza A virus-infected H-2b cells.
Journal of immunology (Baltimore, Md. : 1950) 1994;152(10):4843-51.
-
1992: Cibotti R; Kanellopoulos J M; Cabaniols J P; Halle-Panenko O; Kosmatopoulos K; Sercarz E; Kourilsky P
Tolerance to a self-protein involves its immunodominant but does not involve its subdominant determinants.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(1):416-20.
-
1991: Cabaniols J P; Bolonakis-Tsilivakos I; Cibotti R; Churaqui E; Duc H T; Halle-Pannenko O; Kosmatopoulos K
Mechanism of hybrid resistance. The role of a natural antibody in parental bone marrow cell rejection.
Journal of immunology (Baltimore, Md. : 1950) 1991;146(3):860-4.
-
1989: Cibotti R; Churaqui E; Bolonakis-Tsilivakos I; Scott-Algara D; Hallepannenko O; Kosmatopoulos K
Specific inhibition of hybrid resistance in F1 hybrid mice pretreated with parent-strain spleen cells. III. Study of the mechanism.
Journal of immunology (Baltimore, Md. : 1950) 1989;143(11):3484-91.
-
1988: Kosmatopoulos K; Scott-Algara D; Halle-Pannenko O
Specific inhibition of hybrid resistance in F1 hybrid mice pretreated with parent-strain spleen cells. II. Evidence for an Hh-1 antigen-specific tolerization.
Journal of immunology (Baltimore, Md. : 1950) 1988;141(10):3285-92.
-
1988: Kosmatopoulos K; Scott-Algara D; Orbach-Arbouys S; Halle-Pannenko O
Specific resistance to local graft-versus-host reaction in F1 hybrids pretreated intravenously with parent-strain spleen cells. Role of cytotoxic T lymphocytes directed against receptors for the major histocompatibility complex.
Transplantation 1988;46(4):570-4.
-
1987: Kosmatopoulos K; Scott-Algara D; Cabannes J; Orbach Arbouys S
Suppression of the in vitro parent antihybrid reaction by spleen cells from F1 hybrids pretreated with spleen cells from the opposite parent strain.
Transplantation 1987;44(6):823-31.
-
1987: Kosmatopoulos K; Scott-Algara D; Cabannes J; Orbach-Arbouys S
Specific and nonspecific resistance to local graft-versus-host reaction in F1 hybrids pretreated intravenously with parent-strain spleen cells. I. Two distinct mechanisms.
Transplantation 1987;44(2):267-73.
-
1987: Kosmatopoulos K; Bravo-Cuellar A; Wachowiak J; Orbach-Arbouys S
Inhibition of hybrid resistance by 5-fluorouracil. Destruction of a Thy-1+ Lyt-1+2- spleen cell implicated in the expression of hybrid resistance.
Transplantation 1987;44(2):202-8.
-
1987: Kosmatopoulos K; Orbach-Arbouys S; Mathé G
Specific inhibition of hybrid resistance in B6D2F1 mice pretreated with parental strain B6 cells: role of a nylon-adherent cell induced in the spleen of the B6-pretreated B6D2F1 hybrid.
Transplantation proceedings 1987;19(1 Pt 3):2750-3.
-
1987: Kosmatopoulos K; Algara D S; Orbach-Arbouys S
Anti-receptor anti-MHC cytotoxic T lymphocytes: their role in the resistance to graft vs host reaction.
Journal of immunology (Baltimore, Md. : 1950) 1987;138(4):1038-41.
-
1987: Kosmatopoulos K; Orbach-Arbouys S
Specific suppression of the in vitro parent anti-hybrid reaction. II. Parameters influencing suppressor cell induction in the F1 hybrid.
Cellular immunology 1987;104(2):320-33.
-
1987: Kosmatopoulos K; Bravo-Cuellar A; Scott-Algara D; Orbach-Arbouys S
Specific suppression of the in vitro parent anti-hybrid reaction. I. Characterization of a suppressor cell induced in hybrids by pretreatment with parent-strain spleen cells.
Cellular immunology 1987;104(2):304-19.
-
1987: Kosmatopoulos K; Orbach-Arbouys S
Specific inhibition of hybrid resistance in F1 hybrid mice pretreated with parent strain spleen cells. I. Induction of a nylon-adherent, Thy-1+Lyt-1+2- suppressor cell.
Journal of immunology (Baltimore, Md. : 1950) 1987;138(3):704-12.
Sign-in to see more
